相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Epidemiology, diagnostics, and biomarkers of autoimmune neuromuscular junction disorders
Anna Rostedt Punga et al.
LANCET NEUROLOGY (2022)
Prediction and analysis of microRNAs involved in COVID-19 inflammatory processes associated with the NF-kB and JAK/STAT signaling pathways
Zeinab Amini-Farsani et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2021)
Comparison and optimisation of microRNA extraction from the plasma of healthy pregnant women
Victoria L. Parker et al.
MOLECULAR MEDICINE REPORTS (2021)
Resolvin D1 Improves the Treg/Th17 Imbalance in Systemic Lupus Erythematosus Through miR-30e-5p
Tao Cheng et al.
FRONTIERS IN IMMUNOLOGY (2021)
Identification and Confirmation of the miR-30 Family as a Potential Central Player in Tobacco-Related Head and Neck Squamous Cell Carcinoma
Tingting Zhang et al.
FRONTIERS IN ONCOLOGY (2021)
A novel immune-related ceRNA network that predicts prognosis and immunotherapy response in lung adenocarcinoma
Wei-Jing Gong et al.
ANNALS OF TRANSLATIONAL MEDICINE (2021)
Serum MicroRNA Signature as a Diagnostic and Therapeutic Marker in Patients with Psoriatic Arthritis
Sarah M. Wade et al.
JOURNAL OF RHEUMATOLOGY (2020)
Extracellular vesicles microRNA analysis in type 1 autoimmune pancreatitis: Increased expression of microRNA-21
Koh Nakamaru et al.
PANCREATOLOGY (2020)
Circulating miRNAs as Potential Biomarkers in Myasthenia Gravis: Tools for Personalized Medicine
Liis Sabre et al.
FRONTIERS IN IMMUNOLOGY (2020)
Estrogen Receptor, Inflammatory, and FOXO Transcription Factors Regulate Expression of Myasthenia Gravis-Associated Circulating microRNAs
Alyson A. Fiorillo et al.
FRONTIERS IN IMMUNOLOGY (2020)
Muscle-Specific Kinase Myasthenia Gravis
Lucia S. Borges et al.
FRONTIERS IN IMMUNOLOGY (2020)
Autoimmune Pathology in Myasthenia Gravis Disease Subtypes Is Governed by Divergent Mechanisms of Immunopathology
Miriam L. Fichtner et al.
FRONTIERS IN IMMUNOLOGY (2020)
Outcome Measures in Clinical Trials of Patients With Myasthenia Gravis
Jan Lykke Scheel Thomsen et al.
FRONTIERS IN NEUROLOGY (2020)
Low-dose rituximab lowers serum Exosomal miR-150-5p in AChR-positive refractory myasthenia gravis patients
Huahua Zhong et al.
JOURNAL OF NEUROIMMUNOLOGY (2020)
miR-30e-5p as predictor of generalization in ocular myasthenia gravis
Liis Sabre et al.
ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY (2019)
Chronic inflammatory demyelinating polyneuropathy as an autoimmune disease
Yhojan Rodriguez et al.
JOURNAL OF AUTOIMMUNITY (2019)
Extracellular miRNAs: From Biomarkers to Mediators of Physiology and Disease
Marcelo A. Mori et al.
CELL METABOLISM (2019)
Immunotherapy in myasthenia gravis in the era of biologics
Marinos C. Dalakas
NATURE REVIEWS NEUROLOGY (2019)
Causes and Consequences of miR-150-5p Dysregulation in Myasthenia Gravis
Melanie A. Cron et al.
FRONTIERS IN IMMUNOLOGY (2019)
Immune-related miRNA expression patterns in peripheral blood mononuclear cells differ in multiple sclerosis relapse and remission
Natalia Baulina et al.
JOURNAL OF NEUROIMMUNOLOGY (2018)
Circulating microRNA miR-21-5p, miR-150-5p and miR-30e-5p correlate with clinical status in late onset myasthenia gravis
Liis Sabre et al.
JOURNAL OF NEUROIMMUNOLOGY (2018)
Circulating small non-coding RNAs reflect IFN status and B cell hyperactivity in patients with primary Sjogren's syndrome
Ana P. Lopes et al.
PLOS ONE (2018)
Silencing miR-150 Ameliorates Experimental Autoimmune Encephalomyelitis
Zhaolan Hu et al.
FRONTIERS IN NEUROSCIENCE (2018)
Thymectomy lowers the myasthenia gravis biomarker miR-150-5p
Carl Johan Molin et al.
NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION (2018)
Practical data handling pipeline improves performance of qPCR-based circulating miRNA measurements
Maurice W. J. De Ronde et al.
RNA (2017)
Epstein-Barr virus and multiple sclerosis: Updating Pender's hypothesis
Martin Laurence et al.
MULTIPLE SCLEROSIS AND RELATED DISORDERS (2017)
MicroRNA expression profiles identify disease-specific alterations in systemic lupus erythematosus and primary Sjogren's syndrome
Ji-Qing Chen et al.
PLOS ONE (2017)
Circulating hsa-miR-30e-5p, hsa-miR-92a-3p, and hsa-miR-223-3p may be novel biomarkers in systemic lupus erythematosus
B. -S. Kim et al.
HLA (2016)
Circulating miR-150 in CSF is a novel candidate biomarker for multiple sclerosis
Petra Bergman et al.
NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION (2016)
Disease specific signature of circulating miR-150-5p and miR-21-5p in myasthenia gravis patients
Anna Rostedt Punga et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2015)
Immuno-miRs: critical regulators of T-cell development, function and ageing
Bart-Jan Kroesen et al.
IMMUNOLOGY (2015)
Myasthenia gravis: A comprehensive review of immune dysregulation and etiological mechanisms
Sonia Berrih-Aknin et al.
JOURNAL OF AUTOIMMUNITY (2014)
Circulating miRNAs in myasthenia gravis: miR-150-5p as a new potential biomarker
Tanel Punga et al.
ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY (2014)
Circulating MicroRNAs as biomarkers for disease staging in multiple sclerosis
Roopali Gandhi et al.
ANNALS OF NEUROLOGY (2013)
Assessing sample and miRNA profile quality in serum and plasma or other biofluids
Thorarinn Blondal et al.
METHODS (2013)
Biomarker development for myasthenia gravis
Henry J. Kaminski et al.
MYASTHENIA GRAVIS AND RELATED DISORDERS II (2012)
MicroRNA Expression Profiles as Biomarkers of Minor Salivary Gland Inflammation and Dysfunction in Sjogren's Syndrome
Ilias Alevizos et al.
ARTHRITIS AND RHEUMATISM (2011)
HISTORY OF OUTCOME MEASURES FOR MYASTHENIA GRAVIS
Ted M. Burns
MUSCLE & NERVE (2010)
Autoimmune myasthenia gravis: emerging clinical and biological heterogeneity
Matthew N. Meriggioli et al.
LANCET NEUROLOGY (2009)
Multiple Sclerosis: MicroRNA Expression Profiles Accurately Differentiate Patients with Relapsing-Remitting Disease from Healthy Controls
Andreas Keller et al.
PLOS ONE (2009)
Lifetime course of myasthenia gravis
David Grob et al.
MUSCLE & NERVE (2008)
Analyzing real-time PCR data by the comparative C-T method
Thomas D. Schmittgen et al.
NATURE PROTOCOLS (2008)